Special Issue "Advances in Cell and Immunotherapeutic Approaches to Diabetes"

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: closed (15 December 2021)

Special Issue Editors

Auckland Bioengineering Institute, University of Auckland, Auckland 1142, New Zealand
Interests: diabetes; obesity; cancer; non-communicalbe diseases; marine natural compounds; fucoidan; seaweed; clams; food chemistry; pharmacology; drug metabolism; pharmacokinetics; pre-clinical pharmacology; natural compound extraction; polyamine metabolism; marine bioactives
Special Issues, Collections and Topics in MDPI journals
Translational Type 1 Diabetes Research, Steno Diabetes Center Copenhagen, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark
Interests: autoimmunity; type 1 diabetes; transcriptomics; stem cells; extracellular vesicles; regenerative medicine

Special Issue Information

Cell and immunotherapy seem to be a promising therapeutic approach for diabetes with increasing clinical application. Very similar to type 1 diabetes where the immune system is very much involved in the disease pathogenesis, a growing body of evidence suggests the immune system has a role (especially innate) in triggering/sustaining generalized inflammation in type 2 diabetes. This Special Issue of Biomolecules will highlight original research and reviews on advances in cell and immunotherapeutic approaches in type 1 and type 2 diabetes. Specific topics may include, but are not limited to, immunomodulation, antigen-specific, anti-inflammatory, regulatory T cells, extracellular and stem cell-based therapies for diabetes. Moreover, manuscripts highlighting advanced methods or approaches on preclinical and clinical transplantation and immunotherapeutic studies in the field are welcome.

Prof. Dr. Jun Lu
Dr. Reza Yarani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Cell therapy
  • Immunotherapy
  • Type 1 diabetes
  • Type 2 diabetes
  • Stem cells
  • Extracellular vesicles
  • T regulatory cells
  • Transplantation
  • Immunomodulation.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop